Adrenocorticotropic Hormone (ACTH) (1-39), human 1-39-Corticotropin (human),98.07%

产品编号:Bellancom-P1211| CAS NO:12279-41-3| 分子式:C207H308N56O58S| 分子量:4541.14

Adrenocorticotropic Hormone (ACTH) (1-39), human 是一种黑皮质素受体 (melanocortin receptor) 激动剂。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-P1211
2200.00 杭州 北京(现货)
Bellancom-P1211
5500.00 杭州 北京(现货)
Bellancom-P1211
9400.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Adrenocorticotropic Hormone (ACTH) (1-39), human 1-39-Corticotropin (human)

产品介绍 Adrenocorticotropic Hormone (ACTH) (1-39), human 是一种黑皮质素受体 (melanocortin receptor) 激动剂。
生物活性

Adrenocorticotropic Hormone (ACTH) (1-39), human is a melanocortin receptor agonist.

体外研究

Adrenocorticotropic Hormone (ACTH) (1-39), human (ACTH 1-39), a member of the melanocortin family, stimulates production of CS by the adrenals, but melanocortin receptors are also found in the central nervous system (CNS) and on immune cells. ACTH 1-39 protects neurons in vitro from several apoptotic, excitotoxic and inflammation-related insults. The conditioned medium (CM) is prepared from untreated astroglia (AS) cultures and from AS cultures treated with 200 nM ACTH 1-39 for 24 h, washed to remove ACTH 1-39, then incubated for another 24 h in DMEM. In initial experiments, no difference is found in oligodendroglia (OL) viability in the presence of OL definedmediumwith 2% newborn calf serum (NCS) or AS CM (prepared in DMEM with no serum). After 24 h, OL death under each condition varies between 1 and 4%. Similar results for OL viability are obtained with microglia (MG) CM. In subsequent experiments, controls in each experiment consist of OL in defined medium with 2% NCS.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
体内研究
性状Solid
溶解性数据
In Vitro: 

H2O : ≥ 50 mg/mL (11.01 mM)

* "≥" means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 0.2202 mL 1.1010 mL 2.2021 mL
5 mM 0.0440 mL 0.2202 mL 0.4404 mL
10 mM 0.0220 mL 0.1101 mL 0.2202 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 100 mg/mL (22.02 mM); Clear solution; Need ultrasonic

*以上所有助溶剂都可在 西域 网站选购。
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Sealed storage, away from moisture and light, under nitrogen

Powder -80°C 2 years
-20°C 1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


符号 GHS07 GHS08
GHS07, GHS08
信号词 Warning
危害声明 H302-H312-H332-H351
警示性声明 P280
个人防护装备 Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
危害码 (欧洲) Xn: Harmful;
风险声明 (欧洲) R20/21/22
安全声明 (欧洲) 22-36
危险品运输编码 NONH for all modes of transport
WGK德国 3
RTECS号 GM7900000

服务热线

13911702513
18601927057

微信客服